MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · IEX Real-Time Price · USD
7.16
-0.13 (-1.78%)
At close: Jul 19, 2024, 4:00 PM
7.06
-0.10 (-1.40%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
MiMedx Group Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for MiMedx Group stock have an average target of 12, with a low estimate of 11 and a high estimate of 14. The average target predicts an increase of 67.60% from the current stock price of 7.16.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MiMedx Group stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $11 | Buy | Initiates | $11 | +53.63% | Jul 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +53.63% | May 1, 2024 |
| Lake Street | Lake Street | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +67.60% | Mar 7, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +95.53% | Mar 1, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +67.60% | Oct 31, 2023 |
Financial Forecast
Revenue This Year
368.72M
from 321.48M
Increased by 14.70%
Revenue Next Year
414.29M
from 368.72M
Increased by 12.36%
EPS This Year
0.31
from 0.37
Decreased by -15.64%
EPS Next Year
0.38
from 0.31
Increased by 21.57%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 383.6M | 447.1M | 547.3M | 511.4M | 581.6M |
| Avg | 368.7M | 414.3M | 487.5M | 496.8M | 565.0M |
| Low | 351.5M | 384.4M | 436.8M | 477.3M | 542.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 19.3% | 21.3% | 32.1% | 4.9% | 17.1% |
| Avg | 14.7% | 12.4% | 17.7% | 1.9% | 13.7% |
| Low | 9.3% | 4.2% | 5.4% | -2.1% | 9.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.39 | 0.53 | 1.09 |
| Avg | 0.31 | 0.38 | 0.68 |
| Low | 0.25 | 0.32 | 0.43 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 5.0% | 68.2% | 187.8% |
| Avg | -15.6% | 21.6% | 80.1% |
| Low | -31.1% | 3.6% | 13.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.